China, Sept. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The effect of Sodium-Glucose Cotransporter-2 Inhibitors and Dipeptidyl Peptidase-4 Inhibitors on Diabetic Retinal Disease'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131951
Registration Time: 2026/09/08
Type: Observational study
Primary Sponsor: Department of Ophthalmology and Visual Sciences (DOVS), Chinese University of Hong Kong
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=320678
Published by HT Digital Content Services with permission from Health Daily Digest....